Io Biotech, Inc. recorded an outflow of $82.4M in free cash flow in fiscal year 2024. This represents a decrease of 14.3% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to an outflow of $81.1M in free cash flow. The table below carries 5 fiscal years, from 2020 to 2024, and the quarters Io Biotech, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IOBTQ Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
IOBTQ Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Io Biotech, Inc. financials
Frequently Asked Questions
What was Io Biotech, Inc.'s free cash flow in fiscal year 2024?
Io Biotech, Inc. recorded an outflow of $82.4M in free cash flow in fiscal year 2024.
How fast is Io Biotech, Inc.'s free cash flow growing?
Io Biotech, Inc. (IOBTQ) free cash flow fell by 14.3% year over year, from -$72.1M to -$82.4M in fiscal year 2024.
What is Io Biotech, Inc.'s free cash flow over the last twelve months?
Io Biotech, Inc. (IOBTQ) reported an outflow of $81.1M in free cash flow over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
What was Io Biotech, Inc.'s free cash flow in the most recent quarter?
Io Biotech, Inc. (IOBTQ) reported -$18.5M in free cash flow in Q3 2025. This represents an increase of 11.2% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Io Biotech, Inc. (IOBTQ) reported on that line in every period on record.